← Leaderboards
Sue Ann Ingles
University Of Southern California
$3,809,981
Attributed
$6,042,096
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $676.6K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$6,042,096 · 3
By mechanism
R01$5,595,377 · 2
R21$446,719 · 1
Top collaborators
- Amir Goldkorn5 shared
- Jacek Pinski5 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Jacek Pinski$3,050,227
- Fred R Sattler$24,195,984
- Jean C Shih$8,229,046
- Carrie Van Doren Breton$26,513,887
- Theresa M Bastain$8,140,725
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchAndrogensQuestionnairesHispanic AmericansHuman SubjectCancer CellAndrogen ReceptorDisseminated Malignant NeoplasmCyp17a1 GeneAbirateroneBiologyBlood SpecimenDeprivationCancer PatientCandidate Disease GeneBicalutamideBaseCastrationCellsBiologicalBiological MarkersCancer RiskClinical TrialsAndrogen Antagonists
Grant awards (11)
Biomarkers of Hormone Therapy Response in a Multicenter Prostate Cancer Trial$662,099
R01 · FY2018 · CA
Biomarkers of Hormone Therapy Response in a Multicenter Prostate Cancer Trial$665,642
R01 · FY2017 · CA
Biomarkers of Hormone Therapy Response in a Multicenter Prostate Cancer Trial$669,388
R01 · FY2016 · CA
Biomarkers of Hormone Therapy Response in a Multicenter Prostate Cancer Trial$676,561
R01 · FY2015 · CA
Biomarkers of Hormone Therapy Response in a Multicenter Prostate Cancer Trial$674,482
R01 · FY2014 · CA
A Pilot Study of Novel Candidate Genes for Preeclampsia$243,750
R21 · FY2005 · HD
A Pilot Study of Novel Candidate Genes for Preeclampsia$202,969
R21 · FY2004 · HD
RISK FACTORS FOR ADVANCED PROSTATE CANCER$588,277
R01 · FY2003 · CA
RISK FACTORS FOR ADVANCED PROSTATE CANCER$567,261
R01 · FY2002 · CA
RISK FACTORS FOR ADVANCED PROSTATE CANCER$552,752
R01 · FY2001 · CA
RISK FACTORS FOR ADVANCED PROSTATE CANCER$538,915
R01 · FY2000 · CA